Hollis H. Dsouza

Vasai, MH, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

MCQs on 'ALL induction outcome: Realworld data from a paediatric oncology centre in an LMIC setup with rural predominance'.

MCQs on 'ALL induction outcome: Realworld data from a paediatric oncology centre in an LMIC setup with rural predominance'.

Journal: Indian journal of cancer

Published: July 10, 2024

MCQs on Bortezomib-based induction therapy followed by autologous hematopoietic cell transplantation in newly diagnosed multiple myeloma patients: A single-center experience and review of Indian literature.

MCQs on Bortezomib-based induction therapy followed by autologous hematopoietic cell transplantation in newly diagnosed multiple myeloma patients: A single-center experience and review of Indian literature.

Journal: Indian journal of cancer

Published: January 08, 2024

Phase 3 RCT comparing docetaxel-platinum with docetaxel-platinum-5FU as neoadjuvant chemotherapy in borderline resectable oral cancer.

Phase 3 RCT comparing docetaxel-platinum with docetaxel-platinum-5FU as neoadjuvant chemotherapy in borderline resectable oral cancer.

Journal: European journal of cancer (Oxford, England : 1990)

Published: October 09, 2023

MCQs on "Incidence and clinical profile of brain metastasis treated with whole brain radiotherapy in a tertiary hospital in eastern India: A retrospective audit".

MCQs on "Incidence and clinical profile of brain metastasis treated with whole brain radiotherapy in a tertiary hospital in eastern India: A retrospective audit".

Journal: Indian journal of cancer

Published: October 03, 2023

RMAC study: A randomized study for evaluation of metronomic adjuvant chemotherapy in recurrent head and neck cancers post salvage surgical resection in those who are ineligible for re-irradiation.

RMAC study: A randomized study for evaluation of metronomic adjuvant chemotherapy in recurrent head and neck cancers post salvage surgical resection in those who are ineligible for re-irradiation.

Journal: Oral oncology

Published: August 23, 2021

Chemoradiation in Unresectable Oral Cavity Cancer: A Myth or Reality!

Chemoradiation in Unresectable Oral Cavity Cancer: A Myth or Reality!

Journal: South Asian journal of cancer

Published: June 16, 2021

Thromboembolic events in brain tumour patients on bevacizumab.

Thromboembolic events in brain tumour patients on bevacizumab.

Journal: Acta oncologica (Stockholm, Sweden)

Published: September 08, 2020

Safety and efficacy of bevacizumab biosimilar in recurrent/ progressive glioblastoma.

Safety and efficacy of bevacizumab biosimilar in recurrent/ progressive glioblastoma.

Journal: Ecancermedicalscience

Published: September 05, 2020

Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial.

Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial.

Journal: The Lancet. Global health

Published: March 18, 2020

Phase I/II Study of Palliative Triple Metronomic Chemotherapy in Platinum-Refractory/Early-Failure Oral Cancer.

Phase I/II Study of Palliative Triple Metronomic Chemotherapy in Platinum-Refractory/Early-Failure Oral Cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: September 21, 2019

Nimotuzumab-cisplatin-radiation versus cisplatin-radiation in HPV negative oropharyngeal cancer.

Nimotuzumab-cisplatin-radiation versus cisplatin-radiation in HPV negative oropharyngeal cancer.

Journal: Oncotarget

Published: September 03, 2019

A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer.

A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer.

Journal: Cancer

Published: January 20, 2019

Showing 1-12 of 15

Last Updated: 09/26/2026